Generic Name and Formulations:
Azelastine HCl 137mcg/spray; aqueous nasal spray; contains benzalkonium chloride.
Indications for ASTELIN:
Seasonal allergic rhinitis. Vasomotor rhinitis.
2 sprays in each nostril twice daily.
Seasonal allergic rhinitis: <5yrs: not recommended; 5–11yrs: 1 spray in each nostril twice daily. Vasomotor rhinitis: not recommended.
Avoid eyes. Pregnancy (Cat.C). Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Caution with other antihistamines.
Bitter taste, headache, somnolence, dysesthesia, nasal burning, pharyngitis, dry mouth, paroxysmal sneezing, nausea, rhinitis, fatigue, dizziness, epistaxis, weight increase, myalgia. Children: also conjunctivitis, cough, asthma.
Ready-Spray—30mL (200 sprays)
Psychiatry Advisor Articles
- ADHD, Comorbid Bipolar Disorder Share Similar Neurocognitive Profiles
- Anxiety Prevention Interventions: How Effective Are They?
- Antidepressant Use and Dementia Risk in the Elderly
- No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia
- Sleep Apnea Implant Device Receives FDA Approval
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Duration of Untreated Depression Predicts Depression Severity
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Cognitive Dysfunction a Sign of Prodromal Parkinson Disease
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Bipolar Depression Benefits From Midday Bright Light Therapy